Teva Launches Generic High Blood Pressure Drugs
Teva Pharmaceutical Industries has launched U.S. sales of irbesartan and irbesartan-hydrochlorothiazide tablets, generic versions of Sanofi Aventis' high blood pressure treatments Avapro and Avalide tablets.
The brand products had annual sales of $464 million and $124 million in the United States, based on sales data from the IMS research firm.
Israel-based Teva, the world's largest maker of generic drugs, has been awarded a 180-day period of marketing exclusivity, the company said on Monday.
